Niklason Laura E

President, CEO and Director, DirectorHumacyte, Inc. (HUMA) · full profile →Form 4 · filed Aug 29, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.7M
Net Open-Market Flow
-$5.7M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 29, 2024Sell(S)352K$6.35$2.2M3.7M
Aug 28, 2024Sell(S)277K$6.47$1.8M4.0M
Aug 27, 2024Sell(S)253K$6.71$1.7M4.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001818382-24-000166) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about HUMA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001818382-24-000166"
Ask your agent
Use Arkolith to summarize insider buying and selling at Humacyte, Inc.
over the last 90 days and cite the filings.